TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $447 | -1.8% | 28,926 | -0.2% | 0.04% | 0.0% |
| Q2 2023 | $455 | -4.4% | 28,992 | +0.3% | 0.04% | -9.5% |
| Q1 2023 | $476 | +0.6% | 28,899 | -4.7% | 0.04% | -2.3% |
| Q4 2022 | $473 | -99.9% | 30,322 | -1.0% | 0.04% | +10.3% |
| Q3 2022 | $397,000 | -8.1% | 30,619 | -0.5% | 0.04% | -2.5% |
| Q2 2022 | $432,000 | -2.5% | 30,774 | -0.5% | 0.04% | +14.3% |
| Q1 2022 | $443,000 | +5.2% | 30,919 | 0.0% | 0.04% | +6.1% |
| Q4 2021 | $421,000 | -20.1% | 30,919 | -3.9% | 0.03% | -25.0% |
| Q3 2021 | $527,000 | -4.9% | 32,177 | -2.2% | 0.04% | 0.0% |
| Q2 2021 | $554,000 | -11.8% | 32,906 | -4.4% | 0.04% | -18.5% |
| Q1 2021 | $628,000 | +6.1% | 34,410 | +5.7% | 0.05% | -5.3% |
| Q4 2020 | $592,000 | +0.9% | 32,548 | -1.1% | 0.06% | -10.9% |
| Q3 2020 | $587,000 | +1.9% | 32,904 | +2.4% | 0.06% | -7.2% |
| Q2 2020 | $576,000 | +15.4% | 32,125 | -2.3% | 0.07% | +6.2% |
| Q1 2020 | $499,000 | -22.4% | 32,870 | +0.8% | 0.06% | +1.6% |
| Q4 2019 | $643,000 | +14.6% | 32,614 | 0.0% | 0.06% | -1.5% |
| Q3 2019 | $561,000 | -2.8% | 32,614 | 0.0% | 0.06% | -4.4% |
| Q2 2019 | $577,000 | -15.8% | 32,614 | -3.0% | 0.07% | -15.0% |
| Q1 2019 | $685,000 | – | 33,620 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |